Thomas Catherine A, Grant Stephen G, Pflug Beth R, Getzenberg Robert H, Day Billy W
Department of Environmental and Occupational Health, University of Pittsburgh, Pittsburgh, PA 15260, USA.
Urol Oncol. 2008 Jul-Aug;26(4):378-85. doi: 10.1016/j.urolonc.2007.02.013. Epub 2007 Dec 21.
(Z)-1-1-Dichloro-2,3-diphenylcyclopropane (A(II)) and (Z)-1,1-dichloro-2-(4-methoxyphenyl)-3-phenylcyclopropane [2-(4-methoxyphenyl)-A(II)] inhibit tubulin polymerization, PSA production, and the proliferation of human prostate cancer cells. The actions of the agents were studied in three transgenic adenocarcinomas of the mouse prostate (TRAMP) cell lines. Antiproliferative potencies were determined and cells treated with the more potent 2-(4-methoxyphenyl)-A(II) were examined for induction of apoptosis. Microarray analyses were conducted to determine the apoptosis-related genes up- and down-regulated by the agent. 2-(4-Methoxyphenyl)-A(II) concentration-dependently inhibited growth of all three cell lines. Fifty percent and 100% growth inhibitory and 50% lethal concentrations were determined to be 0.3, 1.5, and 5 muM, respectively. Minimum detectable apoptosis-inducing concentrations by ELISA were 0.10 to 0.14 muM. PARP cleavage and two-color flow cytometry assays verified apoptosis induction. Microarray analyses showed Bok and Siva-pending to be up-regulated and that Birc, Dad1, and Atf5 were down-regulated. 2-(4-methoxyphenyl)-A(II) inhibits proliferation and induces apoptosis in the in vivo-adaptable TRAMP cells, suggesting the compound should be further examined in preclinical models.
(Z)-1,1-二氯-2,3-二苯基环丙烷(A(II))和(Z)-1,1-二氯-2-(4-甲氧基苯基)-3-苯基环丙烷[2-(4-甲氧基苯基)-A(II)]可抑制微管蛋白聚合、前列腺特异性抗原(PSA)生成以及人前列腺癌细胞的增殖。在三种小鼠前列腺转基因腺癌(TRAMP)细胞系中研究了这些药物的作用。测定了抗增殖效力,并对用更有效的2-(4-甲氧基苯基)-A(II)处理的细胞进行凋亡诱导检测。进行基因芯片分析以确定该药物上调和下调的凋亡相关基因。2-(4-甲氧基苯基)-A(II)浓度依赖性地抑制所有三种细胞系的生长。50%和100%生长抑制浓度以及50%致死浓度分别确定为0.3、1.5和5μM。通过酶联免疫吸附测定法(ELISA)检测到的最小可检测凋亡诱导浓度为0.10至0.14μM。聚(ADP-核糖)聚合酶(PARP)裂解和双色流式细胞术检测证实了凋亡诱导。基因芯片分析显示Bok和Siva有待上调,而杆状病毒IAP重复序列(Birc)、死亡结构域相关蛋白1(Dad1)和活化转录因子5(Atf5)则下调。2-(4-甲氧基苯基)-A(II)在体内适应性TRAMP细胞中抑制增殖并诱导凋亡,表明该化合物应在临床前模型中进一步研究。